Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jicheng Yu

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 4, 2023
Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploringYi Li, Huizhong Zhan, Jufang Wu, et al.
Nature Communications|September 14, 2023
Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancerSarun Juengpanich, Shijie Li, Taorui Yang, et al.
Angewandte Chemie (International Ed. in English)|June 17, 2024
Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Metastatic and Postoperative Cancer TreatmentZhengjie Zhao, Yinxian Yang, Tao Sheng, et al.
The Journal of Infection|January 16, 2021
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjectsXiaofen Liu, Yuancheng Chen, Haijing Yang, et al.
Cell|December 10, 2025
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapyYan Xu, Xiaoge Zhang, Xiao Han, et al.
Clinical and Translational Science|July 17, 2024
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypesXiaojie Wu, Nanye Chen, Peiwen Hsu, et al.
British Journal of Clinical Pharmacology|April 30, 2021
Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysisYi Li, Jianda Lu, Yue Kang, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose RegimenYaxin Fan, Yi Li, Yuancheng Chen, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2023
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjectsZhiwei Huang, Xinyi Yang, Yi Jin, et al.
Science Bulletin|March 22, 2024
Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethalityShijie Li, Sarun Juengpanich, Win Topatana, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 4, 2023
Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploringYi Li, Huizhong Zhan, Jufang Wu, et al.
Nature Communications|September 14, 2023
Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancerSarun Juengpanich, Shijie Li, Taorui Yang, et al.
Angewandte Chemie (International Ed. in English)|June 17, 2024
Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Metastatic and Postoperative Cancer TreatmentZhengjie Zhao, Yinxian Yang, Tao Sheng, et al.
The Journal of Infection|January 16, 2021
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjectsXiaofen Liu, Yuancheng Chen, Haijing Yang, et al.
Cell|December 10, 2025
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapyYan Xu, Xiaoge Zhang, Xiao Han, et al.
Clinical and Translational Science|July 17, 2024
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypesXiaojie Wu, Nanye Chen, Peiwen Hsu, et al.
British Journal of Clinical Pharmacology|April 30, 2021
Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysisYi Li, Jianda Lu, Yue Kang, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose RegimenYaxin Fan, Yi Li, Yuancheng Chen, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2023
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjectsZhiwei Huang, Xinyi Yang, Yi Jin, et al.
Science Bulletin|March 22, 2024
Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethalityShijie Li, Sarun Juengpanich, Win Topatana, et al.
Pageof 15